Previous close | 78.28 |
Open | 78.97 |
Bid | 81.03 x 1000 |
Ask | 81.13 x 1400 |
Day's range | 77.64 - 84.11 |
52-week range | 62.55 - 217.25 |
Volume | |
Avg. volume | 4,077,520 |
Market cap | 30.751B |
Beta (5Y monthly) | 1.62 |
PE ratio (TTM) | N/A |
EPS (TTM) | -9.23 |
Earnings date | 21 Feb 2024 - 26 Feb 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 134.16 |
CRISPR Therapeutics AG (CRSP) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Absci (ABSI) announces a collaboration agreement with AstraZeneca to develop an AI-designed antibody for an undisclosed oncology target. The stock rises 13%.
Carnival (NYSE: CCL) (NYSE: CUK) shares have climbed 95% this year, but they're still trading way below their pre-pandemic levels. Things weren't easy for Carnival at the start of the health crisis since it was forced to halt sailings -- and debt ballooned so the company could stay afloat. Carnival's latest earnings reports offer us reason to be optimistic.